Conversely, in ALK fusion-negative NSCLC patients, fusion-positive cases exhibited a relatively lower frequency of TP53 mutation, lower TMB values, and fewer co-mutations [20]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.